Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Change in Acquisitions & Divestments (2023 - 2026)

Contineum Therapeutics' Change in Acquisitions & Divestments history spans 4 years, with the latest figure at $58.1 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 19.46% to $58.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $168.5 million through Mar 2026, up 1.32% year-over-year, with the annual reading at $159.0 million for FY2025, 1.18% up from the prior year.
  • Change in Acquisitions & Divestments came in at $58.1 million for Q1 2026, up from $37.3 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $58.1 million in Q1 2026 to a low of $12.6 million in Q3 2023.
  • The 4-year median for Change in Acquisitions & Divestments is $37.3 million (2025), against an average of $34.7 million.
  • Year-over-year, Change in Acquisitions & Divestments skyrocketed 235.53% in 2024 and then fell 20.35% in 2025.
  • Contineum Therapeutics' Change in Acquisitions & Divestments stood at $31.3 million in 2023, then soared by 44.03% to $45.1 million in 2024, then decreased by 17.3% to $37.3 million in 2025, then soared by 55.73% to $58.1 million in 2026.
  • Per Business Quant, the three most recent readings for CTNM's Change in Acquisitions & Divestments are $58.1 million (Q1 2026), $37.3 million (Q4 2025), and $33.7 million (Q3 2025).